H.R. 5338 was created with the intent to authorize the secretary of state to pursue public/private partnerships, innovative financial mechanisms, research partnerships and coordination with international and multilateral organizations to address childhood cancer globally. The Global Hope Act passed in the House on January 28, 2020 and goes to the Senate Foreign Ralations Committee next for consideration.
If this bill is passed in the Senate, it would call the United States to increase political commitment for both childhood cancer diagnosis and treatment, and support efforts to increase the survival rate of children with cancer globally.
In addition to this, there would be a push to improve access to affordable essential medicine and technology that would provide treatment for these children. And the United States would prioritize efforts in reducing the mortality rate surrounding childhood cancer both within the country and internationally through combined efforts with the United Nations, international health ministries and pharmaceutical companies.
Background: In September 2018, the World Health Organization announced the Global Initiative for Childhood Cancer that aims to reach at least a 60% survival rate for children with cancer by 2030. The Global Hope Act will support this mission and lower the childhood cancer mortality rate in developing countries by:
- Supporting training for medical personnel and building healthcare infrastructure to diagnose, treat, and care for children with cancer;
- Leveraging private sector resources to increase availability of cancer medicines and treatment technology;
- Coordinating with international partners to expand pediatric cancer research; and
- Ensuring that no money will be diverted from existing global health programs.